An angel investor allocated $2,000,000 across 4 early-stage biotech startups. The first received 30%, the second 25%, the third 20%, and the remainder to the fourth. If the fourth startup’s funding was used to grow at a compound rate of 20% annually, what was its value after 3 years?

["Title: How $2M in Angel Investment Fueled Biotech Growth: The 4th Startup’s 3-Year Compound Growth Journey", "In the rapidly evolving world of biotechnology, early-stage funding can make the difference between breakthrough innovation and lost opportunity. Recently, a dedicated angel investor deployed $2 million across four promising early-stage biotech startups—each chosen for its potential to revolutionize medicine and healthcare. With allocations of 30%, 25%, 20%, and the remainder to the fourth company, this investment highlights not only strategic diversification but also long-term value creation.", "The fourth startup received $600,000—exactly 25% of the total funding, totaling $2,000,000. If this capital is reinvested at a steady 20% compound annual growth rate (CAGR), its value can be calculated using the compound interest formula:", "[\nFV = P \ imes (1 + r)^t\n]", "Where:\n- (FV) is the future value\n- (P = 600,000) (initial principal)\n- (r = 0.20) (20% annual return)\n- (t = 3) (years)", "Substituting the numbers:", "[\nFV = 600,000 \ imes (1 + 0.20)^3 = 600,000 \ imes (1.2)^3 = 600,000 \ imes 1.728 = 1,036,800\n]", "After three years, the fourth startup’s investment grows to $1,036,800—a nearly 73% increase driven by disciplined reinvestment and strong market momentum in biotech innovation.", "This example underscores how strategic angel investments, especially when compounded over time, can accelerate progress in life-saving technologies. The $600,000 allocated may one day support novel therapies, clinical trials, or commercialization milestones—proving that smart capital allocation fuels both business success and scientific advancement.", "For investors and innovators alike, this case illustrates the powerful compounding effect of early funding combined with growth-oriented vision—an inspiring blueprint for the future of biotech entrepreneurship.", "---", "Keywords: Angel investor biotech funding, biotech startup investment, compound annual growth rate, early-stage biotech funding, seed investment return, growth investing, biotechnology innovation, startup capital allocation, 20% compound growth, biotech value creation", "Meta Description: Learn how a $600,000 angel investment in a biotech startup grew to $1.0368 million over 3 years at 20% annual compound interest—highlighting the impact of strategic early-stage funding in life sciences innovation."]